The same switch that burns fat could strengthen fragile bones
In the quiet interior of brown fat cells, scientists at McGill University have uncovered a molecular switch — a binding site where glycerol meets an enzyme called TNAP — that activates a hidden heat-producing system the body uses to stay warm. The discovery, published in Nature, is one of those rare findings that answers one question while opening an entirely different door: the same enzyme governs bone mineralization, meaning this switch may hold the key to treating hypophosphatasia, a rare disorder that leaves bones fragile and lives shadowed by fracture. What began as a search for how the body generates warmth has arrived, unexpectedly, at the architecture of human resilience.
- A second heat-producing pathway in brown fat had long been suspected but never explained — until researchers traced its activation to a single molecule, glycerol, binding to a precise pocket on the TNAP enzyme.
- The discovery carries urgency beyond metabolism: TNAP is the same enzyme that fails in hypophosphatasia patients, whose bones remain soft, prone to fracture, and resistant to the treatments available today.
- The condition strikes with particular frequency in Quebec and Manitoba, where inherited mutations cluster, making the search for better therapies not just scientific but deeply regional and human.
- Rather than replacing the broken enzyme — the current therapeutic approach — researchers now see a path to enhancing its activity directly through the glycerol pocket, a more targeted and potentially more powerful intervention.
- Dozens of drug candidates have already been identified for testing, meaning the distance between laboratory discovery and clinical possibility is shorter than it might appear.
Inside brown fat cells, a team led by Lawrence Kazak at McGill University has found a molecular switch that may change how medicine approaches both metabolism and bone disease. The discovery, published in Nature, centers on a question that had lingered for years: what activates the body's second heat-producing system, a pathway that operates alongside the well-known mechanism brown fat uses to generate warmth?
The answer turned out to be glycerol — a molecule released when the body breaks down stored fat in the cold. Working with structural biologist Alba Guarné, Kazak's team found that glycerol binds to an enzyme called TNAP at a site they named the glycerol pocket, triggering what is known as the futile creatine cycle. It was the first time scientists had identified how this alternative pathway is switched on.
What made the finding remarkable was where it led next. TNAP is not only a player in heat production — it is essential for bone mineralization, the process that hardens and strengthens skeletal tissue. When TNAP is deficient, bones remain soft and vulnerable, a condition known as hypophosphatasia. The disorder causes fractures, chronic pain, and skeletal deformities, and it appears with unusual frequency in parts of Canada, particularly Quebec and Manitoba.
Laboratory tests showed that the same molecular switch governing heat in fat cells also influences the cells responsible for building bone. McGill collaborator Marc McKee, who helped develop the first enzyme replacement therapy for hypophosphatasia, sees the glycerol pocket as a new therapeutic target — one that could allow scientists to enhance TNAP's activity rather than simply substitute for it. Dozens of drug candidates are already queued for testing, and what began as an inquiry into warmth has quietly become a potential lifeline for patients whose bones have long been left without adequate defense.
Inside the cells of brown fat, researchers have found a molecular switch that could reshape how we treat fragile bones. The discovery, published in Nature by a team led by Lawrence Kazak at McGill University, reveals how the body activates a hidden energy-burning system—one that scientists didn't know existed until recently.
Brown fat is not like the fat most people think about. While ordinary white fat stores energy, brown fat burns it, generating heat to keep the body warm. Scientists long assumed this heat production relied on a single biological pathway. But over time, evidence emerged of a second pathway working in parallel. The question that lingered was simple: what turns it on?
Kazak's team found the answer in glycerol, a molecule released when the body breaks down stored fat in response to cold. Working with structural biologist Alba Guarné, the researchers discovered that glycerol binds to an enzyme called TNAP at a specific location they named the glycerol pocket. This binding acts as the switch, activating what's known as the futile creatine cycle—the alternative heat-producing system that had remained mysterious. "This is the first time we've identified how an alternative heat-producing pathway is activated, independent of the classic system," Kazak explained. "That opens the door to understanding how multiple energy-burning systems work together to keep the body warm at the just-right temperature."
But the real significance of this finding may have little to do with warmth or weight. TNAP already plays a critical role in bone health. The enzyme is essential for calcification, the process that hardens and strengthens bone tissue. When TNAP doesn't work properly, bones remain soft and vulnerable. This is the hallmark of hypophosphatasia, a rare genetic disorder that causes fractures, pain, and skeletal deformities. The condition appears more frequently in certain Canadian regions, particularly Quebec and Manitoba, where inherited mutations are more common.
Laboratory tests revealed something striking: the same molecular switch that controls heat production in fat cells also directly influences the cells responsible for bone mineralization. This connection opens a new therapeutic avenue. Marc McKee, a collaborator at McGill who has worked on enzyme replacement therapy for hypophosphatasia patients, sees the potential clearly. "This finding opens the door to a new kind of treatment, where increasing the activity of the TNAP enzyme through its glycerol pocket by natural or synthetic bioactive compounds could potentially boost the beneficial actions of the enzyme in patients, to help restore deficient bone mineralization to healthy levels."
The research builds on earlier work that led to the first enzyme replacement therapy for people with defective TNAP. Now, rather than simply replacing the enzyme, scientists could potentially enhance its activity by targeting the glycerol pocket directly. The team has already identified dozens of drug candidates ready for testing. What began as an investigation into how brown fat generates heat has become a potential pathway to treating a disease that leaves bones fragile and lives constrained by the risk of fracture.
Citações Notáveis
This is the first time we've identified how an alternative heat-producing pathway is activated, independent of the classic system. That opens the door to understanding how multiple energy-burning systems work together to keep the body warm.— Lawrence Kazak, McGill University
This finding opens the door to a new kind of treatment, where increasing the activity of the TNAP enzyme through its glycerol pocket by natural or synthetic bioactive compounds could potentially boost the beneficial actions of the enzyme in patients, to help restore deficient bone mineralization to healthy levels.— Marc McKee, McGill University
A Conversa do Hearth Outra perspectiva sobre a história
So you found a switch in brown fat. But why does that matter for bones?
Because the same enzyme that controls the switch—TNAP—is what makes bones hard in the first place. When it doesn't work, bones stay soft and break easily. We found the on button.
And you're saying you can flip that button with a drug?
Not yet. But we've identified dozens of candidates that might. The glycerol pocket is the target. If we can activate TNAP through that pocket, we could help people whose bones never mineralize properly.
How many people are we talking about?
Hypophosphatasia is rare, but it clusters in certain regions—Quebec, Manitoba. The fractures and pain are real. There's already one enzyme replacement therapy, but this could be more elegant.
Why is this discovery important right now?
Because for decades, we thought there was only one way brown fat made heat. Finding a second pathway changed how we understand the whole system. And that led us to TNAP's glycerol pocket. Sometimes the biggest breakthroughs come from asking the right question about something that seems unrelated.
What happens next?
Testing. The candidates go into the lab. If any work, they move toward clinical trials. But the door is open now. We know where to push.